Cargando…

Does the 5–2-1 criteria identify patients with advanced Parkinson's disease? Real-world screening accuracy and burden of 5–2-1-positive patients in 7 countries

BACKGROUND: The burden of Parkinson’s disease (PD) worsens with disease progression. However, the lack of objective and uniform disease classification challenges our understanding of the incremental burden in patients with advanced Parkinson’s disease (APD) and suboptimal medication control. The 5–2...

Descripción completa

Detalles Bibliográficos
Autores principales:	Malaty, Irene A., Martinez-Martin, Pablo, Chaudhuri, K. Ray, Odin, Per, Skorvanek, Matej, Jimenez-Shahed, Joohi, Soileau, Michael J., Lindvall, Susanna, Domingos, Josefa, Jones, Sarah, Alobaidi, Ali, Jalundhwala, Yash J., Kandukuri, Prasanna L., Onuk, Koray, Bergmann, Lars, Femia, Samira, Lee, Michelle Y., Wright, Jack, Antonini, Angelo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8785442/ https://www.ncbi.nlm.nih.gov/pubmed/35073872 http://dx.doi.org/10.1186/s12883-022-02560-1

Ejemplares similares

Psychometric Properties of Clinical Indicators for Identification and Management of Advanced Parkinson’s Disease: Real-World Evidence From G7 Countries
por: Antonini, Angelo, et al.
Publicado: (2022)

Impact of advanced Parkinson’s disease on caregivers: an international real-world study
por: Martinez-Martin, Pablo, et al.
Publicado: (2023)

The Long-Term Impact of Levodopa/Carbidopa Intestinal Gel on ‘Off’-time in Patients with Advanced Parkinson’s Disease: A Systematic Review
por: Antonini, Angelo, et al.
Publicado: (2021)

Comparative Effectiveness of Device-Aided Therapies on Quality of Life and Off-Time in Advanced Parkinson’s Disease: A Systematic Review and Bayesian Network Meta-analysis
por: Antonini, Angelo, et al.
Publicado: (2022)

The Cost Effectiveness of Levodopa-Carbidopa Intestinal Gel in the Treatment of Advanced Parkinson’s Disease in England
por: Chaudhuri, K. Ray, et al.
Publicado: (2022)

Characterizing advanced Parkinson’s disease: OBSERVE-PD observational study results of 2615 patients
por: Fasano, Alfonso, et al.
Publicado: (2019)

Use of a medication-based algorithm to identify advanced Parkinson's disease in administrative claims data: Associations with claims-based indicators of disease severity
por: Dahodwala, Nabila, et al.
Publicado: (2020)

Comparative Effectiveness of Carbidopa–Levodopa Enteral Suspension and Deep Brain Stimulation on Parkinson’s Disease-Related Pill Burden Reduction in Advanced Parkinson’s Disease: A Retrospective Real-World Cohort Study
por: Soileau, Michael J., et al.
Publicado: (2022)

Characteristics of advanced Parkinson's disease patients seen in movement disorder clinics - Australian results from the cross-sectional OBSERVE study
por: Evans, Andrew, et al.
Publicado: (2020)

Intercountry comparisons of advanced Parkinson's disease symptoms and management: Analysis from the OBSERVE‐PD observational study
por: Fasano, Alfonso, et al.
Publicado: (2022)

A new treatment for focal dystonias: incobotulinumtoxinA (Xeomin®), a botulinum neurotoxin type A free from complexing proteins
por: Jimenez-Shahed, Joohi
Publicado: (2012)

Patterns of Daily Motor-Symptom Control with Carbidopa/Levodopa Enteral Suspension Versus Oral Carbidopa/Levodopa Therapy in Advanced Parkinson’s Disease: Clinical Trial Post Hoc Analyses
por: Pahwa, Rajesh, et al.
Publicado: (2022)

Effective Management of “OFF” Episodes in Parkinson’s Disease: Emerging Treatment Strategies and Unmet Clinical Needs
por: Masood, Nbaa, et al.
Publicado: (2023)

Effects of Levodopa-Carbidopa Intestinal Gel on Dyskinesia and Non-Motor Symptoms Including Sleep: Results from a Meta-Analysis with 24-Month Follow-Up
por: Chaudhuri, K. Ray, et al.
Publicado: (2022)

Profile of inhaled levodopa and its potential in the treatment of Parkinson’s disease: evidence to date
por: Patel, Ami B, et al.
Publicado: (2018)

Three Cases of Levodopa-Resistant Parkinsonism After Radiation Therapy
por: Mehanna, Raja, et al.
Publicado: (2016)

Hybrid Feature Extraction for Detection of Degree of Motor Fluctuation Severity in Parkinson’s Disease Patients
por: Hssayeni, Murtadha D., et al.
Publicado: (2019)

GPi Oscillatory Activity Differentiates Tics from the Resting State, Voluntary Movements, and the Unmedicated Parkinsonian State
por: Jimenez-Shahed, Joohi, et al.
Publicado: (2016)

Progressive choreodystonia in X‐linked hyper‐IgM immunodeficiency: a rare but recurrent presentation
por: Škorvánek, Matej, et al.
Publicado: (2022)

Wearable Sensors for Estimation of Parkinsonian Tremor Severity during Free Body Movements
por: Hssayeni, Murtadha D., et al.
Publicado: (2019)

Dyskinesia estimation during activities of daily living using wearable motion sensors and deep recurrent networks
por: Hssayeni, Murtadha D., et al.
Publicado: (2021)

Ensemble deep model for continuous estimation of Unified Parkinson’s Disease Rating Scale III
por: Hssayeni, Murtadha D., et al.
Publicado: (2021)

Long-Term Persistence and Monotherapy with Device-Aided Therapies: A Retrospective Analysis of an Israeli Cohort of Patients with Advanced Parkinson’s Disease
por: Thaler, Avner, et al.
Publicado: (2022)

Prediction of STN-DBS Electrode Implantation Track in Parkinson's Disease by Using Local Field Potentials
por: Telkes, Ilknur, et al.
Publicado: (2016)

Impact of the COVID-19 outbreak on neurological consultation in an emergency department
por: Maretta, Milan, et al.
Publicado: (2022)

Levodopa–carbidopa intestinal gel in a subgroup of patients with dyskinesia at baseline from the GLORIA Registry
por: Poewe, Werner, et al.
Publicado: (2019)

Comparative Effectiveness of Carbidopa/Levodopa Enteral Suspension and Deep Brain Stimulation on Pill Burden Reduction in Medicare Fee-for-Service Patients with Advanced Parkinson’s Disease
por: Soileau, Michael J., et al.
Publicado: (2023)

Accuracy of Rating Scales and Clinical Measures for Screening of Rapid Eye Movement Sleep Behavior Disorder and for Predicting Conversion to Parkinson’s Disease and Other Synucleinopathies
por: Skorvanek, Matej, et al.
Publicado: (2018)

The role and structure of the multidisciplinary team in the management of advanced Parkinson’s disease with a focus on the use of levodopa–carbidopa intestinal gel
por: Pedersen, Stephen W, et al.
Publicado: (2017)

Deutetrabenazine in Tics Associated with Tourette Syndrome
por: Jankovic, Joseph, et al.
Publicado: (2016)

The long‐term direct and indirect economic burden among Parkinson's disease caregivers in the United States
por: Martinez‐Martin, Pablo, et al.
Publicado: (2018)

Update on the Management of Parkinson's Disease for General Neurologists
por: Pirtošek, Zvezdan, et al.
Publicado: (2020)

Expression of LGR-5, MSI-1 and DCAMKL-1, putative stem cell markers, in the early phases of 1,2-dimethylhydrazine-induced rat colon carcinogenesis: correlation with nuclear β-catenin
por: Femia, Angelo Pietro, et al.
Publicado: (2013)

Eating disorder diagnostics in the digital era: validation of the Norwegian version of the Eating Disorder Assessment for DSM-5 (EDA-5)
por: Dahlgren, Camilla Lindvall, et al.
Publicado: (2020)

Deep Brain Stimulation for Obsessive Compulsive Disorder: Evolution of Surgical Stimulation Target Parallels Changing Model of Dysfunctional Brain Circuits
por: Karas, Patrick J., et al.
Publicado: (2019)

Unsupervised clustering reveals spatially varying single neuronal firing patterns in the subthalamic nucleus of patients with Parkinson's disease
por: Kaku, Heet, et al.
Publicado: (2019)

Systematic review and comparison of pharmacologic therapies for neuropathic pain associated with spinal cord injury
por: Snedecor, Sonya J, et al.
Publicado: (2013)

Characterization of advanced Parkinson’s disease in Germany: results of the non-interventional OBSERVE-PD study
por: Pedrosa, David J., et al.
Publicado: (2022)

Subthalamic Single Cell and Oscillatory Neural Dynamics of a Dyskinetic Medicated Patient With Parkinson's Disease
por: Ozturk, Musa, et al.
Publicado: (2020)

Dissection of a locus on mouse chromosome 5 reveals arthritis promoting and inhibitory genes
por: Lindvall, Therese, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_j9a7fl1qnbhlqpqk3uqr3an88r